Vaughan & CO Securities, Inc. Gsk PLC Transaction History

Vaughan & CO Securities, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$42.05 - $47.77 $8,410 - $9,554	-200 Reduced 1.19%	16,667 $726,000
Q1 2022 Apr 21, 2022	SELL	$40.23 - $47.74 $5,229 - $6,206	-130 Reduced 0.76%	16,867 $735,000
Q4 2021 Jan 27, 2022	BUY	$38.88 - $45.31 $20,139 - $23,470	518 Added 3.14%	16,997 $750,000
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $179,814 - $209,932	5,247 Added 46.71%	16,479 $588,000
Q4 2020 May 11, 2021	SELL	$34.07 - $39.94 $10,663 - $12,501	-313 Reduced 2.71%	11,232 $414,000
Q2 2020 May 10, 2021	SELL	$37.87 - $43.58 $43,209 - $49,724	-1,141 Reduced 8.99%	11,545 $471,000
Q1 2020 May 28, 2020	SELL	$32.47 - $48.83 $1,071 - $1,611	-33 Reduced 0.26%	12,686 $490,000
Q4 2019 Feb 04, 2020	BUY	$42.0 - $48.25 $534,198 - $613,691	12,719 New	12,719 $609,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Vaughan & CO Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Vaughan & CO Securities, Inc. with notifications on news.